India and United States vow to jointly act against emerging drug threats

India and the United States recently agreed to undertake coordinated action against emerging narcotic threats during a high-level bilateral meeting. The Narcotics Control Bureau hosted the <b>2nd India-US Drug Policy Executive Working Group Meeting</b> on November 2-3. The Indian delegation was led by NCB Director General Anurag, while the US side was headed by Debbie Seguin from the Office of National Drug Control Policy. Both sides reviewed bilateral cooperation, identifying priority areas for strengthening intelligence sharing, precursor control, and pharmaceutical supply chain integrity. Both nations agreed to share best practices to disrupt transnational drug trafficking networks and promote demand reduction. The NCB DG also highlighted India's <b>Vision Roadmap 2026-2029</b> during the discussions to ensure sustained institutional engagement.